GlassScriptPhysician profile
Grace Lee Peng
NPI 1508107475
$2,161.39
in general payments reported to CMS, 2019-2025
11 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $188 · 2021: $174 · 2022: $244 · 2023: $153 · 2024: $742 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $584.07 | 2022-2025 | |
| Allergan, INC. | $322.79 | 2019-2022 | |
| Stryker Corporation | $258.35 | 2019-2025 | Xpress Loprofile, Scopis Ent |
| Axogen | $229.35 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Baxter Healthcare | $195.67 | 2024 | Perclot |
| Smith+Nephew, INC. | $146.67 | 2024 | Ent Sinus |
| Acclarent, INC | $133.63 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $127.90 | 2019 | |
| Revance Therapeutics, INC. | $87.30 | 2024 | Daxxify |
| Apyx Medical Corporation | $49.89 | 2020 | |
| Merz North America, INC. | $25.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Peng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.